Your CDSCO-Compliant Pharmacovigilance System — Built for Reliability

End-to-end drug safety services for Marketing Authorization Holders across India and global markets. Purpose-built to meet CDSCO circular mandates and IPC PV Guidance Version 2.0.

  • CDSCO-registered CRO
  • MedDRA Licensed
  • ICH E2B(R3) Submissions
  • 20+ Years Experience

20+

Years of Experience

13

PV Services

100%

CDSCO Compliant

Global

Submission Capability

CDSCO Circular — June 2026: All Marketing Authorization Holders are now legally required to establish an effective Pharmacovigilance system. Auriga Research is ready to support your compliance journey.

About Our PV Services

Protecting Patients. Ensuring Compliance.

Pharmacovigilance (PV) is the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. In India, the Central Drugs Standard Control Organisation (CDSCO) mandates all Marketing Authorization Holders — manufacturers, marketers, and importers of licensed drugs — to maintain an active, audit-ready PV system.

Auriga Research Pvt. Ltd. is a CDSCO-registered Contract Research Organisation (CRO) with over 20 years of experience. Our pharmacovigilance team handles everything from initial system setup to ongoing safety monitoring, ICSR submissions, aggregate report writing, and independent audits — so you remain compliant without building an in-house team.

Why Auriga

Your Trusted PV Partner

Rapid Deployment

Your PV system goes live quickly from SLA signing — structured onboarding with no lengthy delays.

Regulatory Expertise

In-depth knowledge of CDSCO requirements, IPC PV Guidance V2.0, ICH guidelines, GVP Modules, and NDCT Rules 2019.

Global Submission Capability

Direct E2B(R3) XML submissions to EMA, US FDA, and MHRA from a single platform.

AI-Powered Platform

AI-assisted case narrative generation, signal detection analytics, and automated compliance checks.

Full Training Support

SOP development, team training and a Document Management System ensure your staff is always audit-ready.

True End-to-End Coverage

13 PV services under one roof — from first ICSR to annual aggregate report to independent audit.

Common Questions

Frequently Asked Questions

Is it mandatory for all MAHs to have a PV system in India?
Yes. Following CDSCO's June 2026 circular and the NDCT Rules 2019, every Marketing Authorization Holder — whether a manufacturer, marketer or importer — is legally obligated to maintain an effective Pharmacovigilance system. Non-compliance may attract regulatory action.
Can Auriga set up PV for small or mid-sized pharma companies?
Absolutely. Our services are designed to be scalable. Whether you have 2 products or 200, we offer flexible service packages. We handle everything from PvMF creation to ICSR processing on your behalf.
How quickly can we get started?
Onboarding timelines depend on the number of products and complexity of your safety database requirements. Our team works with you to agree a structured implementation plan from SLA signing through to go-live.

Ready to Build Your Pharmacovigilance System?

Contact our PV team for a free 30-minute consultation or a live demonstration of the Auriga Safety System.

Type to search services, tests, and locations…